CEP Magazine
Should Highly Regulated Public Companies Have Board-Level Compliance Committees?
November 2021
In this CEP Magazine article, Sidley partners Holly J. Gregory and Paul E. Kalb, MD, the co-chair of Sidley’s Executive Compensation and Corporate Governance practice and the global head of Sidley’s Healthcare and FDA Group, respectively, discuss the considerations evaluating whether highly regulated public companies should have board-level compliance committees.
Copyright 2021 CEP Magazine, a publication of the Society of Corporate Compliance and Ethics (SCCE).
Offices
得意分野
Suggested News & Insights
Zync v. Porsche: Omissions in Hydrogen Bombs and Corporate FilingsAugust 4, 2026Alignment Is Not Control: Court of Chancery Dismisses the KnowBe4 ChallengeJuly 29, 2026Timing Is Everything: Section 220 Standing After a Merger ClosesJuly 23, 2026Sidley Represents Grupo Comercial Chedraui and Chedraui USA in US$300 Million RefinancingJuly 21, 2026Inspection Rights, Internal Affairs, and Personal Jurisdiction: Orchid Global’s Procedural LessonJuly 15, 2026Delaware Court of Chancery Dismisses Stockholder Claims as Derivative, Unripe, and UntimelyJuly 14, 2026
- Stay Up To DateSubscribe to Sidley Publications
- Follow Sidley on Social MediaSocial Media Directory